worcesterherald.com
Holden, MA: Sevo Nutraceuticals Announces Publication of PERCEPTIV™ Clinical Studies Funded by Alzheimer’s Association - Worcester Herald
Sevo Nutraceuticals, Inc. announced today that PERCEPTIV™ Phase II clinical trial results were published this month in the online version of the Journal of Alzheimer's Disease . PERCEPTIV is its clinically proven, cognitive health supplement available to the public without a prescription. UMASS L
WorcesterHerald